Skip to main content

Strattera News

Taking ADHD Meds Won't Raise a Kid's Odds for Drug Abuse Later: Study

THURSDAY, July 6, 2023 – Stimulant medications like Ritalin are commonly prescribed to help treat the symptoms of attention deficit hyperactivity disorder, but there have been concerns the drugs may...

FDA Medwatch Alert: Methylphenidate ADHD Medications: Drug Safety Communication - Risk of Long-lasting Erections

ISSUE: FDA is warning that methylphenidate products (including Concerta, Daytrana, Focalin/Focalin XR, Metadate CD/Metadate ER, Methylin/Methylin ER, Quillivant XR, Ritalin/Ritalin LA/Ritalin SR),...

FDA Medwatch Alert: Strattera (atomoxetine) - Sep 29, 2005

[Posted 09/29/2005] The FDA directed Eli Lilly and Company (Lilly), the manufacturer of Strattera (atomoxetine), to revise the prescribing information to include a boxed warning and additional...

FDA Medwatch Alert: Strattera (atomoxetine) - Dec 21, 2004

FDA notified health care professionals about a new warning for Strattera, a drug approved for attention deficit hyperactivity disorder (ADHD) in adults and children. The labeling is being updated...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Attention-Deficit Hyperactivity Disorder (ADHD)

Strattera patient information at Drugs.com